Expertenrunde
OCT-Priorisierung nach COVID-19
10. Juni 2020
· 50 Min. Videodauer
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.100.100.file/dr-ike-ahmed.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.360.360.file/dr-ike-ahmed.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.768.768.file/dr-ike-ahmed.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/dr-ike-ahmed.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original./dr-ike-ahmed.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original./dr-ike-ahmed.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/dr-ike-ahmed.jpg/_jcr_content/renditions/original./dr-ike-ahmed.jpg"})
Autor
Ike Ahmed, MD
Prism Eye Institute, Kanada
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.100.100.file/schlenker-m.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.360.360.file/schlenker-m.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.768.768.file/schlenker-m.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/schlenker-m.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original./schlenker-m.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original./schlenker-m.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/275-oct-prioritization-post-covid-19/images/schlenker-m.jpg/_jcr_content/renditions/original./schlenker-m.jpg"})
Autor
Matt Schlenker, MD
Kensington Eye Institute, Kanada
ZUSAMMENFASSUNG
Einsatz und Priorisierung von OCT für das Glaukom-Management nach COVID-19
In dieser brandaktuellen Diskussion tauschen Ike Ahmed, MD, und Matt Schlenker, MD, ihre Ideen zum optimalen Glaukom-Patientenmanagement und zur Priorisierung der OCT nach COVID-19 aus. Wenn nun endlich der Rückstau an Patienten abgearbeitet werden kann, die für persönliche Beratungen und Untersuchungen in die Praxis kommen müssen, sollten ihrer Meinung nach 4 Dinge beachtet werden:
- Strategien, um Glaukom-Patienten per Telemedizin ophthalmologisch zu untersuchen
- Kenntnis der effizientesten Möglichkeiten der Beurteilung anhand von Bildern unter Berücksichtigung der Struktur-Funktion-Korrelation
- Nutzung einzelner Ausdrucke zur Krankheitsbeurteilung und Identifizierung von Artefakten
- Die Bedeutung der Progressionsanalyse nach COVID-19